Clinical Trials Logo

Filter by:
NCT ID: NCT02122757 Withdrawn - Sporadic Migraine Clinical Trials

Anodal Transcranial Direct Current Stimulation of the Visual Cortex Versus Sham Stimulation in the Episodic Migraine

ANODEM
Start date: September 2013
Phase: N/A
Study type: Interventional

Anodal tDCS increases the excitability of the cerebral cortex and its daily application during intercritical phase, may have a therapeutic effect in episodic migraine.

NCT ID: NCT02122744 Withdrawn - Chronic Migraine Clinical Trials

RCT Versus Placebo of rTMSQP Over Visual Cortex for the Prevention of Chronic Migraine

Start date: September 2013
Phase: N/A
Study type: Interventional

Evaluation of inhibiting rTMS QP over the visual cortex for the prevention of chronic migraine. The aim of the study is to confirm that inhibiting rTMS QP is capable to decrease the frequency of migraine and if its effect is stronger than placebo effect.

NCT ID: NCT02053597 Withdrawn - Breast Cancer Clinical Trials

TRIal evalUating the Menstrual and Ovarian Function of Young Breast Cancer Patients Treated With a cycloPHosphamide-free Regimen

TRIUMPH
Start date: October 2014
Phase: Phase 2
Study type: Interventional

Recently, there has been a rising trend of delaying childbearing and hence more women are diagnosed with breast cancer before completing their families. Given the continuous decline in recurrences and death secondary to breast cancer and the reassuring data on the safety of pregnancy following breast cancer more women are inquiring into the possibility of preserving fertility following chemotherapy. The challenge remains in using a regimen that is devoid of cyclophosphamide, but is as effective as the standard regimens that incorporate cyclophosphamide. The combination doxorubicin (50 mg/m2) and paclitaxel (200 mg/m2) (AP) followed by 12 weeks of paclitaxel (80 mg/m2) (P) emerges as a treatment option with convincing results regarding its effectiveness in the early setting, and could be potentially associated with less ovarian toxicity being devoid of cyclophosphamide.

NCT ID: NCT02025946 Withdrawn - Arthritis Clinical Trials

Observational Study of Total Ankle Arthroplasty and Tibiotalar Arthrodesis

Start date: n/a
Phase: N/A
Study type: Observational

In case of severe ankle arthritis, the two common surgical treatments are tibiotalar arthrodesis and total ankle arthroplasty. Few studies have compared these treatments and it remains difficult to determine which operation is the better solution for end stage ankle arthritis. The purpose of the present study is to analyze patient's outcome after each type of ankle surgery and to describe the decision making process.

NCT ID: NCT02017366 Withdrawn - Esophageal Cancer Clinical Trials

Design of the EFECTS Trial

EFECTS
Start date: October 2018
Phase: N/A
Study type: Interventional

It is well known that there is a considerable postoperative weight loss in patients undergoing esophageal resection for cancer. We believe that this weigh loss can be limited by administering postoperative enteral feeding (target: 1000 kCal/ day) via feeding jejunostomy for at least 6 weeks postoperatively. We hypothesize that patients undergoing esophageal resection for cancer will have a better overall survival with postoperative additional enteral feeding than when on regular oral diet alone.

NCT ID: NCT01992276 Withdrawn - Influenza Clinical Trials

Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection

Start date: December 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the rate of decline in quantitative viral load measured in hospitalized patients with Influenza A infection

NCT ID: NCT01991925 Withdrawn - Clinical trials for Hereditary Haemochromatosis

Implications for Quality of Life and Quality of Care in Patients With Hereditary Haemochromatosis

Start date: April 2016
Phase:
Study type: Observational

Patients with hereditary haemochromatosis will be interviewed/questioned about their Quality of life and the delivered quality of care in the hospital.

NCT ID: NCT01973504 Withdrawn - Trauma Clinical Trials

Phase 2c Dose Comparison Study of MP4OX in Trauma

Start date: December 2013
Phase: Phase 2
Study type: Interventional

MP4OX is being developed as an ischemic rescue therapy to perfuse and oxygenate tissues at risk during hemorrhagic shock. MP4OX is a pegylated hemoglobin-based colloid designed to improve perfusion and target delivery of oxygen to ischemic tissues. This study will evaluate safety and efficacy of MP4OX treatment, in addition to standard therapy, in trauma patients suffering from lactic acidosis due to severe hemorrhagic shock.

NCT ID: NCT01953289 Withdrawn - Appendicitis Clinical Trials

Importance of Peritoneal Free Fluid Cultures in Acute Appendicitis

IFFSA
Start date: July 2012
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate the frequency of positive free fluid cultures in both perforated and non-perforated appendicitis. In addition predictors of positive free fluid cultures will be analyzed.

NCT ID: NCT01951833 Withdrawn - Clinical trials for Cystic Fibrosis (CF)

Long Term Significance (Survival) of LCI in Patients With Cystic Fibrosis

Start date: January 2013
Phase: N/A
Study type: Observational

The current dream in CF research is to discover safe drugs that correct the basic defect and prevent lung disease, allowing patients without significant lung damage to live nearly normal lives with a dramatic increase in life expectancy and without the burden of current treatment. The compound VX-770 (Ivacaftor Ò) is hoped to be the first milestone along this way. Progression of lung disease is now so gradual in many centres that sensitive indicators of early lung disease (small airways disease) are critically needed to assess the effects of such new treatments. In this context, assessment of ventilation inhomogeneity by the measurement called Lung clearance index (LCI) seems to be the most promising tool. However, to get approval by health authorities, new measures used in drug evaluation need to fulfill strict criteria. For LCI, the investigators still need to prove its long term significance: How well does the LCI measurement predict the long term lung disease course? Therefore, in this study the investigators want to measure LCI at baseline in a large patient cohort and establish how well it predicts the patients' disease course over the next 2 years.